|Bid||121.98 x 1400|
|Ask||122.10 x 1100|
|Day's range||120.66 - 122.00|
|52-week range||87.68 - 122.05|
|Beta (5Y monthly)||0.77|
|PE ratio (TTM)||54.01|
|Earnings date||27 May 2021|
|Forward dividend & yield||2.32 (1.90%)|
|Ex-dividend date||25 Mar 2021|
|1y target est||133.71|
Medtronic's (MDT) ventilator sales are robust and prospects of the Diabetes arm remain strong amid the pandemic.
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities.
As the World Health Organization spearheads a global campaign on equity this World Health Day, the Medtronic Foundation and Children's HeartLink (CHL) are announcing a $2.5 million, three-year, outcomes-based partnership to address congenital heart disease in children with a focus on reducing disparities in access to care and quality patient outcomes, and meaningful employee engagement. This partnership continues a rich collaborative legacy across the organizations, and is made in honor of Omar Ishrak, former chairman and CEO, Medtronic and former board member of the Medtronic Foundation, a true champion of impact driven philanthropy focusing on the underserved.